Oral manifestations caused by the linear IgA disease;Manifestaciones orales de la enfermedad por depósito lineal de IgA

Medicina Oral

Volumn 9, Issue 1, 2004, Pages 39-44

  Eguia Del Valle, Asier ^a,c   Aguirre Urízar, José Manuel ^a   Martínez Sahuquillo, Angel ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c NONE   (Spain)

Author keywords

Autoantibodies; Linear IgA disease; Mucocutaneous disease; Oral manifestations

Indexed keywords

AUTOANTIBODY; BETAMETHASONE; CLOBETASOL; COLCHICINE; CORTICOSTEROID; DAPSONE; FLUOCINOLONE; PREDNISONE; SULFAPYRIDINE; SULFONAMIDE; TRIAMCINOLONE;

AGRANULOCYTOSIS; AUTOIMMUNE DISEASE; BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; CANDIDIASIS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ENTEROPATHY; ERYTHEMA; ERYTHEMA MULTIFORME; EYE DISEASE; FEVER; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEPOSITION; KIDNEY DISEASE; LETHARGY; LEUKOPENIA; MEGALOBLASTIC ANEMIA; MOUTH LESION; MOUTH MUCOSA; NEUROLOGIC DISEASE; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRURITUS; RASH; REVIEW; SKIN DEFECT; SKIN MANIFESTATION; STOMACH DISEASE; TERATOGENESIS; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VOMITING;

AUTOIMMUNE DISEASES; HUMANS; IMMUNOGLOBULIN A; MOUTH DISEASES; MUCOUS MEMBRANE; SKIN DISEASES;

EID: 0942290727     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blisterins diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:517-34.
2. Katz SI, Strober W. The pathogenesis of dermatitis herpetiformis. J Invest Dermatol 1978;70:63-75.
3. VanJoost T, Faber WR, Westerhof W, deMari F. Linear epidermal IgA deposition in bullous penphigoid. Acta Derm Venereol 1979;59:463-5.
4. Wilson BD, Beutner EH, Kumar V, Chorleski TP, Jablonska S. Linear IgA bullous dermatitits: an immunologically defined disease. J Dermatol 1985;24:569-74.
5. Chorzelski T, Jablonska S. Evolving concept of IgA linear dermatosis. Semin Dermatol 1988;7:225-32.
6. Ahkami R, Thomas I. Linear IgA bullous dermatosis associated with vancomycin and diseminated varicella-zoster infection. Cutis 2001;67:423-6.
7. Wiadrowski TP, Reid CM. Drug-induced linear IgA bullous disease following antibiotics. Autralas J Dermatol 2001;42:196-9.
8. Danielsen AG, Thomsen K. Vancomycin-induced linear IgA bullous disease. Br J Dermatol 1999;141:756-7.
9. Girao L, Fiadeiro T, Rodriges JC. Burn-induced linear IgA dermatosis. J Eur Acad Dermatol Venereol 2000;14:507-10.
10. Van Der Wall RI, Van De Scheur MR, Pas HH, Jonkman MF, Van Groeningen CJ, Nieboer C, et al. Linear IgA bullous dermatosis in a patient with renal cell carcinoma. Br J Dermatol 2001;144:870-3.
11. Stuber E, Swensson O, Nitsche R, Nickel T, Sticherling M, Christophers E, et al. Association of lymphocytic colitis with linear IgA dermatosis. Z Gastroenterol 1999;37:519-23.
12. Wong DA, Hunt MJ, Stapleton K. IgA multiple myeloma presenting as an acquired bullous disorder. Australas J Dermatol 1999;40:31-4.
13. Christophoridis S, Budinger L, Borradori L, Hunziker T, Merk HF, Hertl M. IgG, IgA and IgE autoantibodies against the ectodomain of BP 180 in patients with bullous and cicatricial pemphigoid and linear IgA dermatosis. Br J Dermatol 2000;143:349-55.
14. Roh JY, Yee C, Lazarova Z, Hall RP, Yancey KB. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Br J Dermatol 2000;143:104-11.
15. Fujimoto W, Ohtsu T, Toi Y, Nakanishi G, Arata J. Linear IgA disease with IgA antibodies directed against 200- and 280-kDa epidermal antigens. Br J Dermatol 2000;142:1213-8.
16. Zillikens D. Acquired skin disease of hemidesmosomes. J Dermatol Sci 1999;20:134-54.
17. Zillikens D, Giudice GJ. BP 180/type XVII collagen: its role in acquired and inherited disorders of the dermal-epidermal junction. Arch Dermatol Res 1999;291:187-94.
18. Cowan CG, Lamey PJ, Walsh M, Irwin ST, Allen G, Mckenna KE. Linear IgA disease (LAD): immunoglobulin deposition in oral and colonic lesions. J Oral Pathol Med 1995;24:374-8.
19. Georgi M, Scheckenbach C, Kromminga A, Partscht K, Messer G, Brcker EB, et al. Mapping of etiotopes on the BP 180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease. Arch Dermatol Res 2001;293:109-14.
20. Caproni M, Rolfo S, Bernacchi E, Bianchi B, Brazzini B, Fabbri P. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of IgA bullous dermatosis. Br J Dermatol 1999;140:1072-8.
21. Williams DM. Non-infectious diseases of the oral soft tissue: a new approach. Adv Dent Res 1993;7:213-9.
22. Weisenfeld D, Martín A, Scully C, Thomson J. Oral manifestations in linear IgA disease. Br Dent J 1982;153:398-9.
23. Chan LS, Regezi JA, Cooper KD. Oral manifestations of linear IgA disease. J Am Acad Dermatol 1990;22:362-5.
24. Kelly SE, Frith PA, Millard PR, Wojnarowska F, Black MM. A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol 1988;119:161-70
25. Cohen DM, Bhattacharyya I, Zunt SL, Tomich CE. Linear IgA disease histopathologically and clinically masquerading as lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:196-201.
26. Porter SR, Scully C, Midda M, Eveson JW. Adult linear immunoglobulin A disease manifesting as desquamative gingivitis. Oral Surg Oral Med Oral Pathol 1990;70:450-3.
27. Porter SR, Bain SE, Scully C. Linear IgA disease manifesting as recalcitrant desquamative gingivitis. Oral Surg Oral Med Oral Pathol 1992;74:179-82.
28. Zone JJ, Smith EP, Powell D. Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA. Dermatol 1994;189:64-6.
29. Pulimood S, Ajithkumar K, Jacob M, George S, Chandi SM. Linear IgA bullous dermatosis of childhood: treatment with dapsone and co-trimoxazole. Clin Exp Dermatol 1997;22:90-1.
30. Tingle MD, Mahmud R, Maggs JL, Pirmohamed M, Park BK. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man. J Pharmacol Exp Ther 1997;283:817-23.
31. McFadden JP, Leonard JN, Powles AV, Rutman AJ, Fry L. Sulpamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 1989;121:759-62.
32. Ang P, Tay YK. Treatment of linear IgA bullous dermatosis of childhood with colchicine. Pediatr Dermatol 1999;16:50-2.
33. Tay YK, Ang P. Treatment of linear IgA bullous dermatosis of childhood with colchicine: in reply. Pediatr Dermatol 2000;17:157-8.
34. Aram H. Linear IgA bullous dermatosis. Successful treatment with colchicine. Arch Dermatol 1984;120:960-1.
35. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998;28:48-59.